Discover the EMA's role in promoting safe medicine access in the EU. Learn about its responsibilities in drug evaluation, ...

While it may have been a chaotic year for the US Food and Drug Administration (FDA) due to layoffs, leadership changes and ...

The agency is approaching the new overhaul as a chance to reshape drug regulations in the European Union.

Anavex Life Sciences (AVXL) has formally asked the European Medicines Agency to re-examine its opinion made earlier in December that the company's treatment for early-stage Alzheimer's, blarcamesine, ...

The recommendation addresses a long-standing treatment gap for patients facing bladder removal after standard therapy fails.

Despite reported slowing of progression, regulators said the evidence on the novel oral agent blarcamesine did not support a ...